Experimental Drug Development Centre Reveals Updated Phase 1 Data on Antibody-Drug Conjugate EBC-129 at ASCO 2025
In a groundbreaking development for pancreatic cancer therapy, the Experimental Drug Development Centre (EDDC) in Singapore has unveiled compelling updates ...